Dr Reddy's Laboratories has inked a pact with Teva Pharmaceutical and an affiliate of Allergan Plc to buy a portfolio of eight abbreviated new drug applications (ANDAs) in the US for $ 350 million (around Rs 2,300 crore) in c
The US Consumer Product Safety Commission (US CPSC) has approached the US Department of Justice seeking action against Dr Reddy's Laboratories in a 5-year old case involving packaging for five blister-packed prescription prod
Dr Reddy's Laboratories shares plunged as much as 2.24 per cent on Thursday after reports that the US Consumer Product Safety Commission charges company for packaging lapses in at least five prescription drugs.
Dr Reddy's Laboratories shares fell 2.9 per cent in morning trade after its consolidated net profit declined by 85.6 per cent to Rs 74.6 crore for the March quarter on account of provisioning for outstanding receivables from
DRL will be granted exclusive US rights for the development and commercialisation of XenoPort’s clinical-stage oral new chemical entity, XP23829 Dr Reddy’s Laboratories (DRL) and XenoPort have entered into a license a